Quantitative molecular imaging of viral therapy for pancreatic cancer using an engineered measles virus expressing the sodium-iodide symporter reporter gene.
about
Imaging characteristics, tissue distribution, and spread of a novel oncolytic vaccinia virus carrying the human sodium iodide symporterOncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapySodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancerStem Cell Imaging: Tools to Improve Cell Delivery and Viability.Oncolytic viral therapy for pancreatic cancer: current research and future directionsThe sodium iodide symporter (NIS) as an imaging reporter for gene, viral, and cell-based therapiesThe use of the NIS reporter gene for optimizing oncolytic virotherapySodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer[18F]tetrafluoroborate-PET/CT enables sensitive tumor and metastasis in vivo imaging in a sodium iodide symporter-expressing tumor modelViral oncolysis - can insights from measles be transferred to canine distemper virus?Systemic therapy of disseminated myeloma in passively immunized mice using measles virus-infected cell carriers.Normalisation to blood activity is required for the accurate quantification of Na/I symporter ectopic expression by SPECT/CT in individual subjects.Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine.Image-guided, tumor stroma-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated NIS gene deliveryOncolytic virotherapy for pancreatic cancer.Image-guided tumor-selective radioiodine therapy of liver cancer after systemic nonviral delivery of the sodium iodide symporter gene.Attenuated oncolytic measles virus strains as cancer therapeuticsIn vivo bioimaging tracks conditionally replicative adenoviral replication and provides an early indication of viral antitumor efficacy.The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics.Reporter gene imaging identifies intratumoral infection voids as a critical barrier to systemic oncolytic virus efficacy.Oncolytic measles virus strains as novel anticancer agents.Targeting murine heart and brain: visualisation conditions for multi-pinhole SPECT with (99m)Tc- and (123)I-labelled probes.The biology of the sodium iodide symporter and its potential for targeted gene delivery.Monitoring the initial delivery of an oncolytic measles virus encoding the human sodium iodide symporter to solid tumors using contrast-enhanced computed tomographyUse of attenuated paramyxoviruses for cancer therapy.The use of molecular imaging of gene expression by radiotracers in gene therapy.Immunotherapeutic potential of oncolytic vaccinia virus.Potential and clinical translation of oncolytic measles viruses.Arming viruses in multi-mechanistic oncolytic viral therapy: current research and future developments, with emphasis on poxviruses.Advances in the design and development of oncolytic measles viruses.Novel oncolytic viral therapies in patients with thoracic malignancies.Viral dose, radioiodide uptake, and delayed efflux in adenovirus-mediated NIS radiovirotherapy correlates with treatment efficacy.In situ study of the impact of inter- and intra-reader variability on region of interest (ROI) analysis in preclinical molecular imagingTreatment of pancreatic cancer using an oncolytic virus harboring the lipocalin-2 gene.Oncolytic virotherapy as an immunotherapeutic strategy for multiple myeloma.Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models.Estimation of Oncolytic Virus Populations within Tumors
P2860
Q21134124-C14291AE-74C8-4A44-B8DC-076C28580D65Q24605512-9B4803F2-7306-4F44-A66B-F55051349F7FQ24611278-82FDC721-537C-41D4-B955-B256688A4135Q26765843-0DB3B0CE-74DD-4DA1-BC3B-CFA335EDC847Q27011439-1CB33CCF-52DE-4B25-9087-4C3E1FE556F0Q27023157-A5F16208-C622-4E48-AFD2-1534A2C7F41DQ28083534-38654C69-85F6-43A3-BC8C-927C75D7D314Q33603806-15BD8AD6-B0F6-4C40-9B4A-C23F77D09D37Q33680923-58B4F897-8D4B-48FA-8F77-64DC69A332DAQ33820717-218FF200-9893-46C7-B9C3-2B2211F2894FQ33930081-33F8C25E-F9B4-4D81-B66A-CF243D8591EAQ34217690-F0C275F4-E4FB-42F3-B19D-15FC849C7718Q34470472-F7AB8F64-754D-4190-87B0-D8FBFA149191Q35238289-AF79AE04-4819-4904-A9A7-69CF1A6CE4C6Q35590996-9112FD18-1313-4204-838A-6255F0D56E19Q35612571-F7F7B41B-1FD9-4A21-B455-D8D59B12CFBBQ35818876-8562ADD0-9737-4B88-A0CC-8010AC8030BBQ36097074-EF006F6E-BA1B-4A80-AC90-7F9375520A37Q36128415-FDDBA22F-4548-4775-9A25-5717A2412949Q36664219-E724DA79-E102-473C-80DE-BBB1ECE77DFFQ37261017-8AE5C64C-55E8-4989-845D-08BAF1716D47Q37299537-4CD0C5C1-27E4-4729-957A-CB6BD1F3EFA4Q37564872-4101CC9A-FD0B-42EE-92AE-EFCA96AF49F0Q37594715-CEE5663A-F812-4663-8BAB-675073A78006Q37810599-1D8903CE-68AC-4192-8FA7-6B03380F48BAQ37884052-127D3678-F75C-4B2D-A9AA-890839D7C722Q37895969-AB5183E5-CFC5-4FDA-8424-AFF8AD931579Q38764947-6BFDAC7B-4BCA-4DAB-A4BC-82A9DD77C3AEQ38924539-01745EC1-75CD-4F2B-8BD4-517E591143ECQ38924566-BD78930C-B88A-4221-ABBF-CB2538E20CF3Q39067827-51A047FF-0BBB-4D24-8B8B-33D65B0694D5Q39280068-39F7348E-A462-42D0-A4CC-A1F215173E6DQ41828483-DDFB9983-F1CE-4AD6-98A7-2F6653012A4FQ45358201-14B858A8-AAD5-49E1-9593-ED4038A84335Q47326177-01712B90-8AE8-45BD-8E60-C52615A08D2EQ51731081-01BECF2E-8C51-4A0B-897D-C5066F984788Q57462027-D6524A9F-33AE-4550-880E-0291A8212ADD
P2860
Quantitative molecular imaging of viral therapy for pancreatic cancer using an engineered measles virus expressing the sodium-iodide symporter reporter gene.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Quantitative molecular imaging ...... odide symporter reporter gene.
@en
Quantitative molecular imaging ...... odide symporter reporter gene.
@nl
type
label
Quantitative molecular imaging ...... odide symporter reporter gene.
@en
Quantitative molecular imaging ...... odide symporter reporter gene.
@nl
prefLabel
Quantitative molecular imaging ...... odide symporter reporter gene.
@en
Quantitative molecular imaging ...... odide symporter reporter gene.
@nl
P2093
P2860
P356
P1476
Quantitative molecular imaging ...... odide symporter reporter gene.
@en
P2093
Bradley J Kemp
Claire E Bender
Elizabeth M Hadac
Kelly L Classic
Stephanie K Carlson
P2860
P304
P356
10.2214/AJR.08.1205
P407
P577
2009-01-01T00:00:00Z